Michelle Rasmussen, MD
Obstetrics & Gynecology · Plano, TXNPI 1447811708
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 85 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,017, more than ten times the $23 reported in 2021.
Across 85 payments — averaging $24.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$349
- Astellas Pharma US Inc$211
- Mayne Pharma Commercial LLC$202
- Pfizer$182
- Myriad Women's Health, Inc.$143
- Sage Therapeutics, LLC$137
- plus $826 from 16 others
What the payments were for
- Food & beverage$1,93894%
- Education$1136%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 10 | $349 |
| Astellas Pharma US Inc | 7 | $211 |
| Mayne Pharma Commercial LLC | 9 | $202 |
| Pfizer | 12 | $182 |
| Myriad Women's Health, Inc. | 1 | $143 |
| Sage Therapeutics, LLC | 8 | $137 |
| Millicent US Inc | 8 | $136 |
| Lilly USA, LLC | 1 | $121 |
| Hologic Sales And Service, LLC | 3 | $109 |
| Exeltis, USA Inc. | 6 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Axonics, Inc. | 3 | $53 |
| Meditrina | 2 | $41 |
| Boston Scientific | 2 | $41 |
| Integra Lifesciences Corporation | 2 | $27 |
| American Regent | 1 | $26 |
| Innovation Technologies Inc | 1 | $25 |
| BD | 1 | $18 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $17 |
| Evofem Biosciences, Inc. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$143
- ZEPBOUND$121
- ANNOVERA$118
- NEXTSTELLIS$118
How this compares
$2,051 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 37 | $1,484 |
| Raloxifene Hcl | 16 | $996 |
| Clobetasol Propionate | 13 | $281 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Plano
- Elizabeth CoronadoPlano$155K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.